Atrás
Rango del Día
$1,225.66
$1,249.83
Rango de 52 Semanas
$946.69
$1,525.17
Volumen
120,004
Promedio 50D / 200D
$1,353.91
/
$1,321.41
Cierre Anterior
$1,204.48
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (626 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 29.1 | 0.4 |
| P/B | — | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | 21.6 | 3.8 |
| Rev Growth 5Y % | 2.0 | 10.0 |
| D/E | — | 0.2 |
Puntos Clave
Revenue grew 2.01% annually over 5 years — modest growth
Net margin of 21.59% shows strong profitability
Generating 848.65M in free cash flow
Cash machine — converts 97.64% of earnings into free cash flow
Capital efficient — spends only 2.66% of revenue on capex
ROIC of 36.16% — excellent capital efficiency
Crecimiento
Revenue Growth (5Y)
2.01%
Revenue (1Y)3.98%
Earnings (1Y)0.70%
FCF Growth (3Y)-0.69%
Calidad
Return on Equity
N/A
ROIC36.16%
Net Margin21.59%
Op. Margin27.78%
Seguridad
Debt / Equity
N/A
Current Ratio1.14
Interest Coverage16.32
Valoración
P/E Ratio
29.12
P/B RatioN/A
EV/EBITDA24.67
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3.98% | Revenue Growth (3Y) | 3.09% |
| Earnings Growth (1Y) | 0.70% | Earnings Growth (3Y) | 4.97% |
| Revenue Growth (5Y) | 2.01% | Earnings Growth (5Y) | 3.11% |
| Profitability | |||
| Revenue (TTM) | 4.03B | Net Income (TTM) | 869.19M |
| ROE | N/A | ROA | 23.41% |
| Gross Margin | 57.52% | Operating Margin | 27.78% |
| Net Margin | 21.59% | Free Cash Flow (TTM) | 848.65M |
| ROIC | 36.16% | FCF Growth (3Y) | -0.69% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.14 |
| Interest Coverage | 16.32 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 29.12 | P/B Ratio | N/A |
| P/S Ratio | 6.29 | PEG Ratio | 8.96 |
| EV/EBITDA | 24.67 | Dividend Yield | 0.00% |
| Market Cap | 25.31B | Enterprise Value | 27.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.03B | 3.87B | 3.79B | 3.92B | 3.72B |
| Net Income | 869.19M | 863.14M | 788.78M | 872.50M | 768.99M |
| EPS (Diluted) | 42.17 | 40.67 | 35.90 | 38.41 | 32.78 |
| Gross Profit | 2.32B | 2.25B | 2.17B | 2.24B | 2.11B |
| Operating Income | 1.12B | 1.13B | 1.08B | 1.13B | 994.74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3.71B | 3.24B | 3.36B | 3.49B | 3.33B |
| Total Liabilities | 3.74B | 3.37B | 3.51B | 3.47B | 3.16B |
| Shareholders' Equity | -23.64M | -126.89M | -149.94M | 24.79M | 171.42M |
| Total Debt | 2.34B | 2.13B | 2.20B | 2.13B | 1.80B |
| Cash & Equivalents | 66.89M | 59.36M | 69.81M | 95.97M | 98.56M |
| Current Assets | 1.36B | 1.19B | 1.23B | 1.38B | 1.27B |
| Current Liabilities | 1.20B | 1.17B | 1.18B | 1.15B | 1.15B |